Serum biochemistry
Screening for trisomy 21
Trisomic pregnancies are associated with altered maternal serum concentrations of various feto-placental products.
Screening in the second trimester by maternal age and various combinations of total or free ß-hCG, AFP, uE3 and Inhibin A can identify 56-71% of trisomy 21 pregnancies for a false positive rate of 5%.
Screening in the first trimester by a combination of maternal age, fetal NT, FHR and serum free ß-hCG and PAPP-A identifies about 90% of trisomy 21 pregnancies for a false positive rate of 3%.

